Medtronic plc (MDT)

Medtronic Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Year Ending	TTM	Apr 26, 2024	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021	Apr 24, 2020
Cash & Equivalents	1,284	1,284	1,543	3,714	3,593	4,140
Short-Term Investments	6,721	6,721	6,416	6,859	7,224	6,808
Cash & Cash Equivalents	8,005	8,005	7,959	10,573	10,817	10,948
Cash Growth	0.58%	0.58%	-24.72%	-2.26%	-1.20%	11.17%
Receivables	6,128	6,128	5,998	5,551	5,462	4,645
Inventory	5,217	5,217	5,293	4,616	4,313	4,229
Other Current Assets	2,585	2,585	2,425	2,319	1,956	2,209
Total Current Assets	21,935	21,935	21,675	23,059	22,548	22,031
Property, Plant & Equipment	6,131	6,131	5,569	5,413	5,221	4,828
Goodwill and Intangibles	54,211	54,211	56,269	56,097	59,701	58,904
Other Long-Term Assets	7,704	7,704	7,435	6,412	5,613	4,926
Total Long-Term Assets	68,046	68,046	69,273	67,922	70,535	68,658
Total Assets	89,981	89,981	90,948	90,981	93,083	90,689
Accounts Payable	2,410	2,410	2,662	2,276	2,106	1,996
Current Debt	1,092	1,092	20	3,742	11	2,776
Other Current Liabilities	7,287	7,287	6,369	6,376	6,392	5,594
Total Current Liabilities	10,789	10,789	9,051	12,394	8,509	10,366
Long-Term Debt	23,932	23,932	24,344	20,372	26,378	22,021
Other Long-Term Liabilities	4,840	4,840	5,888	5,494	6,594	7,430
Total Long-Term Liabilities	28,772	28,772	30,232	25,866	32,972	29,451
Total Liabilities	39,561	39,561	39,283	38,260	41,481	39,817
Total Debt	25,024	25,024	24,364	24,114	26,389	24,797
Debt Growth	2.71%	2.71%	1.04%	-8.62%	6.42%	-2.08%
Retained Earnings	30,403	30,403	30,392	30,250	28,594	28,132
Comprehensive Income	-3,318	-3,318	-3,499	-2,265	-3,485	-3,560
Shareholders' Equity	50,214	50,214	51,483	52,551	51,428	50,737
Net Cash / Debt	-17,019	-17,019	-16,405	-13,541	-15,572	-13,849
Net Cash Per Share	-12.79	-12.79	-12.31	-10.02	-11.50	-10.25
Working Capital	11,146	11,146	12,624	10,665	14,039	11,665
Book Value Per Share	37.82	37.82	38.72	39.15	38.24	37.84

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).